Cerebral clearance of human amyloid-β peptide (1-40) across the blood-brain barrier is reduced by self-aggregation and formation of low-density lipoprotein receptor-related protein-1 ligand complexes
Cerebral clearance of human amyloid-β peptide (1-40) across the blood-brain barrier is reduced by self-aggregation and formation of low-density lipoprotein receptor-related protein-1 ligand complexes
复制标题
DOI:
10.1111/j.1471-4159.2007.04938.x
复制
发表时间:
2007-12-01
影响因子:
4.7
通讯作者:
Terasaki, Tetsuya
中科院分区:
文献类型:
--
作者:
Ito, Shingo;Ohtsuki, Sumio;Terasaki, Tetsuya
Soluble amyloid-beta peptide (A beta) exists in the form of monomers and oligomers, and as complexes with A beta-binding molecules, such as low-density lipoprotein receptor-related protein-1 (LRP-1) ligands. The present study investigated the effect of self-aggregation and LRP-1 ligands on the elimination of human A beta(1-40) [hA beta(1-40)] from the rat brain across the blood-brain barrier. Incubation of [I-125]hA beta(1-40) monomer resulted in time-dependent and temperature-dependent dimer formation, and the apparent elimination rate of [I-125]hA beta(1-40) dimer was significantly decreased by 92.7% compared with that of [I-125]hA beta(1-40) monomer. Pre-incubation with LRP-1 ligands, such as activated alpha 2-macroglobulin (alpha 2M), apolipoprotein E2 (apoE2), apoE3, apoE4, and lactoferrin, reduced the elimination of [I-125]hA beta(1-40). By contrast, pre-administration of the same concentration of these molecules in the rat brain did not significantly inhibit [I-125]hA beta(1-40) monomer elimination. Purified [I-125]hA beta(1-40)/activated alpha 2M complex and [I-125]activated alpha 2M were not significantly eliminated from the rat brain up to 60 min. MEF-1 cells, which have LRP-1-mediated endocytosis, exhibited uptake of [I-125]activated alpha 2M, and enhancement of [I-125]hA beta(1-40) uptake upon pre-incubation with apoE, suggesting that [I-125]activated alpha 2M and [I-125]hA beta(1-40)/apoE complex function as LRP-1 ligands. These findings indicate that dimerization and LRP-1-ligand complex formation prevent the elimination of hA beta(1-40) from the brain across the blood-brain barrier.